About

Born on August 1, 1920 in Roanoke, Virginia, Lacks lived a humble life as a tobacco farmer and mother of five. In 1951, she was diagnosed with an aggressive form of cervical cancer and sought treatment at Johns Hopkins Hospital in Baltimore, Maryland. During her treatment, a small sample of her tumor cells was taken without her permission, a common practice at the time. Little did Lacks know that her cells would become immortal and unique in biomedicine. Known as HeLa cells, they were the first human cells to be successfully grown in a laboratory setting, continuously dividing and reproducing. Scientists soon realized the remarkable attributes of these cells as they allowed for significant advances in medical research, including the development of polio vaccines, cancer treatments, and the comprehension of various diseases. However, the story of Henrietta Lacks and her contribution to science remained largely unknown for decades. Her cells were commercialized without her family's knowledge or consent, resulting in numerous ethical and legal controversies. It was not until the 1970s, when scientists began to use the term "HeLa cells," that Lacks' family became aware of their mother's invaluable contribution to science. In recent years, Henrietta Lacks' story has gained attention and recognition. Her case has sparked discussions about patient rights, informed consent, and the ethical implications of using human cells for research. The Henrietta Lacks Foundation was established to honor her legacy and provide support for her descendants. Henrietta Lacks died on October 4, 1951, at the age of 31, leaving behind a lasting scientific legacy. Her story serves as a reminder of the crucial role that individual contributions, sometimes made unknowingly, can play in advancing medical science and the importance of ethical practices in research.